Let us recall (NPI) VIOXX:
“On September 30, 2004, Merck withdrew rofecoxib from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use. Merck withdrew the drug after disclosures that it withheld information about rofecoxib’s risks from doctors and patients for over five years, resulting in between 88,000 and 140,000 cases of serious heart disease [2] of which roughly half died. [citation needed] Rofecoxib was one of the most widely used drugs ever to be withdrawn from the market. In the year before withdrawal, Merck had sales revenue of US$2.5 billion from Vioxx.”
It was that, or the FDA would have done it for them. By my count:
Example Supp = 4 deaths, no FDA oversight
Vioxx= 44,000 deaths, with full FDA approval
Draw your own conclusions.
